Pfizer Liability for Increased Risk of Diabetes in Women Using Lipitor

Get Legal Help Today

 Secured with SHA-256 Encryption

Jeffrey Johnson is a legal writer with a focus on personal injury. He has worked on personal injury and sovereign immunity litigation in addition to experience in family, estate, and criminal law. He earned a J.D. from the University of Baltimore and has worked in legal offices and non-profits in Maryland, Texas, and North Carolina. He has also earned an MFA in screenwriting from Chapman Univer...

Full Bio →

Written by

UPDATED: Jul 15, 2021

Advertiser Disclosure

It’s all about you. We want to help you make the right legal decisions.

We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.

Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.

Pfizer could be liable for fraud for failing to place warnings on their drug Lipitor which increased the chance of diabetes in women. According to litigation experts, manufacturer Pfizer did not provide adequate warnings about the cholesterol-reducing drug, despite medical studies highlighting the associated risk.

What is Lipitor?

Lipitor is one of the most popular drugs available for the treatment of reducing cholesterol, with sales of over 125 billion since it’s release in 1997. However, a study done in 1996 indicated that Lipitor’s adverse affects included the increased risk of diabetes. This information was not adequately communicated to doctors, placing patients at risk.

Pfizer negligently failed to warn about the risk of diabetes

Pfizer failed to place warnings on its labels, thereby failing to give Doctors sufficient information to properly care for their patients. Doctors were not warned that when they prescribed Lipitor, they would need to closely monitor patients who might already have, or who might be at risk, of diabetes. Pfizer had a duty to place a warning on their labelling if there is a serious hazard with a drug. This misrepresentation of Lipitor’s side effects can make the manufacturer liable for fraud.

Misleading study data

In 1996, the Food and Drug Administration (FDA) failed to order Pfizer to conduct additional tests after Pfizer’s initial tests of Lipitor showed it increased the risk of diabetes. The FDA ruled out the need of further tests and approved the drug based on representations made by Pfizer. The tests indicated doctors should be made aware of the risk and especially about the need to monitor patients who might be vulnerable to diabetes, factors which Pfizer did not disclose when they began marketing the drug. Other studies by Pfizer on the full adverse affects of Lipitor were combined with data of other similar but less at-risk statin drugs, resulting in misleading results. By not accurately demonstrating the real impact of the drug’s effects on women’s health, a serious breach of care for patients resulted.

Consult with an Attorney

If you have used Lipitor and suffered adverse side effects, you should consult with an experienced injury and product attorney immediately. You can discuss possible litigation against the manufacturer Pfizer. The disregard for the rights and safety of consumers can warrant damages for those affected by Lipitor.

Get Legal Help Today

Find the right lawyer for your legal issue.

 Secured with SHA-256 Encryption